Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism
Top Cited Papers
- 22 November 2006
- journal article
- research article
- Published by Wiley in American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics
- Vol. 141B (8) , 947-956
- https://doi.org/10.1002/ajmg.b.30366
Abstract
Autism is a behaviorally defined neurodevelopmental disorder usually diagnosed in early childhood that is characterized by impairment in reciprocal communication and speech, repetitive behaviors, and social withdrawal. Although both genetic and environmental factors are thought to be involved, none have been reproducibly identified. The metabolic phenotype of an individual reflects the influence of endogenous and exogenous factors on genotype. As such, it provides a window through which the interactive impact of genes and environment may be viewed and relevant susceptibility factors identified. Although abnormal methionine metabolism has been associated with other neurologic disorders, these pathways and related polymorphisms have not been evaluated in autistic children. Plasma levels of metabolites in methionine transmethylation and transsulfuration pathways were measured in 80 autistic and 73 control children. In addition, common polymorphic variants known to modulate these metabolic pathways were evaluated in 360 autistic children and 205 controls. The metabolic results indicated that plasma methionine and the ratio of S‐adenosylmethionine (SAM) to S‐adenosylhomocysteine (SAH), an indicator of methylation capacity, were significantly decreased in the autistic children relative to age‐matched controls. In addition, plasma levels of cysteine, glutathione, and the ratio of reduced to oxidized glutathione, an indication of antioxidant capacity and redox homeostasis, were significantly decreased. Differences in allele frequency and/or significant gene–gene interactions were found for relevant genes encoding the reduced folate carrier (RFC 80G > A), transcobalamin II (TCN2 776G > C), catechol‐O‐methyltransferase (COMT 472G > A), methylenetetrahydrofolate reductase (MTHFR 677C > T and 1298A > C), and glutathione‐S‐transferase (GST M1). We propose that an increased vulnerability to oxidative stress (endogenous or environmental) may contribute to the development and clinical manifestations of autism.Keywords
This publication has 84 references indexed in Scilit:
- G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanismLife Sciences, 2005
- Cerebrospinal Fluid and Serum Markers of Inflammation in AutismPublished by Elsevier ,2005
- Association of MTRR A66G polymorphism (but not of MTHFR C677T and A1298C, MTR A2756G, TCN C776G) with homocysteine and coronary artery disease in the French populationThrombosis and Haemostasis, 2005
- Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteinsLife Sciences, 2004
- Genetic and Neurochemical Modulation of Prefrontal Cognitive Functions in ChildrenAmerican Journal of Psychiatry, 2004
- Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosisThe Journal of Pediatrics, 2003
- Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2001
- RECEPTOR-MEDIATED ENDOCYTOSIS OF COBALAMIN (VITAMIN B12)Annual Review of Nutrition, 1999
- The neurological syndrome of infantile cobalamin deficiency: Developmental regression and involuntary movementsMovement Disorders, 1997
- Long-term neurologic consequences of nutritional vitamin B12 deficiency in infantsThe Journal of Pediatrics, 1992